вторник, 14 марта 2017 г.

Two-part Ebola vaccine offers long-lasting protection

Two-part Ebola vaccine offers long-lasting protection


The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. The two-part shot from Johnson & Johnson and Danish partner Bavarian Nordic induced a durable immune response lasting a full year in 100 percent of healthy volunteers vaccinated, researchers reported.



from Biotech News